Have your own idea? Try our Stock Screener
The Biotech is pretty flat in the last 7 days, but ME Therapeutics Holdings has stood out, gaining 23%. The past year has been better, since the industry has gained 19% in that time. Looking forward, earnings are expected to remain mostly flat in the next few years.
Has the Canadian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 24 Jan 2025 | CA$1.5b | CA$87.5m | -CA$318,059,042.03 | 25.9x | -4.7x | 17.1x |
Sun, 22 Dec 2024 | CA$1.5b | CA$85.5m | -CA$330,832,137.94 | 15.4x | -4.4x | 17x |
Tue, 19 Nov 2024 | CA$1.3b | CA$83.3m | -CA$248,916,369.03 | 8.6x | -5.1x | 15.1x |
Thu, 17 Oct 2024 | CA$1.3b | CA$80.3m | -CA$279,545,279.84 | 9x | -4.7x | 16.3x |
Sat, 14 Sep 2024 | CA$947.2m | CA$80.3m | -CA$282,348,766.81 | 9.4x | -3.4x | 11.8x |
Mon, 12 Aug 2024 | CA$1.1b | CA$76.1m | -CA$325,799,137.96 | 11.1x | -3.4x | 14.3x |
Wed, 10 Jul 2024 | CA$1.1b | CA$76.1m | -CA$335,903,967.68 | 10.6x | -3.4x | 14.8x |
Fri, 07 Jun 2024 | CA$1.2b | CA$76.8m | -CA$341,614,172.29 | 11.3x | -3.6x | 16.1x |
Sun, 05 May 2024 | CA$911.8m | CA$78.8m | -CA$301,405,544.77 | 317.4x | -3x | 11.6x |
Tue, 02 Apr 2024 | CA$1.1b | CA$88.1m | -CA$313,844,503.30 | 11.1x | -3.6x | 12.8x |
Thu, 29 Feb 2024 | CA$1.3b | CA$93.2m | -CA$321,480,833.45 | 10.7x | -4x | 13.7x |
Sat, 27 Jan 2024 | CA$3.5b | CA$86.3m | -CA$516,590,021.00 | 6.9x | -6.8x | 41x |
Mon, 25 Dec 2023 | CA$3.6b | CA$86.1m | -CA$521,808,413.00 | 6.9x | -6.9x | 41.7x |
Wed, 22 Nov 2023 | CA$3.8b | CA$86.7m | -CA$545,090,789.00 | 5.5x | -7x | 44.3x |
Fri, 20 Oct 2023 | CA$3.8b | CA$89.0m | -CA$532,712,398.00 | 5.2x | -7.1x | 42.3x |
Sun, 17 Sep 2023 | CA$3.9b | CA$88.8m | -CA$517,650,902.00 | 5.7x | -7.6x | 44.3x |
Tue, 15 Aug 2023 | CA$4.0b | CA$85.8m | -CA$523,663,687.00 | 6.9x | -7.6x | 46.7x |
Thu, 13 Jul 2023 | CA$4.1b | CA$81.5m | -CA$516,136,071.00 | 13.2x | -7.9x | 50.1x |
Sat, 10 Jun 2023 | CA$3.9b | CA$86.5m | -CA$548,508,397.00 | 11.5x | -7.1x | 44.7x |
Mon, 08 May 2023 | CA$3.8b | CA$82.3m | -CA$581,680,732.00 | 12.3x | -6.5x | 45.9x |
Wed, 05 Apr 2023 | CA$2.4b | CA$90.5m | -CA$600,699,509.00 | 9.5x | -4x | 26.3x |
Fri, 03 Mar 2023 | CA$2.7b | CA$90.4m | -CA$590,404,646.00 | 8.2x | -4.6x | 29.8x |
Sun, 29 Jan 2023 | CA$3.0b | CA$86.5m | -CA$523,179,882.00 | 11.3x | -5.8x | 34.9x |
Tue, 27 Dec 2022 | CA$3.1b | CA$87.6m | -CA$534,348,821.00 | 10.3x | -5.7x | 34.8x |
Thu, 24 Nov 2022 | CA$3.1b | CA$88.1m | -CA$573,926,479.00 | 14.8x | -5.4x | 35.1x |
Sat, 22 Oct 2022 | CA$3.1b | CA$86.1m | -CA$551,596,803.00 | 15.1x | -5.6x | 35.8x |
Mon, 19 Sep 2022 | CA$3.4b | CA$85.1m | -CA$539,656,961.00 | 13.5x | -6.3x | 39.8x |
Wed, 17 Aug 2022 | CA$3.5b | CA$84.4m | -CA$520,907,009.00 | 13.8x | -6.6x | 40.9x |
Fri, 15 Jul 2022 | CA$3.5b | CA$183.4m | -CA$611,495,266.00 | 10.1x | -5.8x | 19.3x |
Sun, 12 Jun 2022 | CA$3.1b | CA$180.3m | -CA$594,902,790.00 | 13.2x | -5.2x | 17.3x |
Tue, 10 May 2022 | CA$3.2b | CA$182.9m | -CA$479,551,218.00 | 12.6x | -6.6x | 17.3x |
Thu, 07 Apr 2022 | CA$3.6b | CA$170.3m | -CA$480,928,805.00 | 15.2x | -7.4x | 20.9x |
Sat, 05 Mar 2022 | CA$3.1b | CA$170.1m | -CA$473,897,140.00 | 15.5x | -6.6x | 18.5x |
Mon, 31 Jan 2022 | CA$3.2b | CA$168.1m | -CA$434,585,446.00 | 18.4x | -7.4x | 19.2x |
-7.4x
Which industries have driven the changes within the Canadian Healthcare industry?
CA Market | 2.29% | |
Healthcare | 0.071% | |
Biotech | -1.12% | |
Biotech | -1.12% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ONCO Onco-Innovations | CA$2.20 | 51.7% +CA$32.5m | n/a | PB2794.6x | |
METX ME Therapeutics Holdings | CA$7.00 | 11.3% +CA$17.9m | 586.3% | n/a | |
HEM Hemostemix | CA$0.35 | 27.3% +CA$10.5m | 366.7% | PE-24.7x | |
MBX Microbix Biosystems | CA$0.50 | 13.6% +CA$8.1m | 25.0% | PE19.3x | |
EDT Spectral Medical | CA$0.51 | 4.1% +CA$6.4m | 0% | PS72.3x |